Operating Profit Margin
since 2005
Calculation
Cytokinetics Inc., operating profit margin, long-term trends, calculation
| Operating profit margin | = | 100 | × | Operating income (loss)1 | ÷ | Revenues1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2022 | -342.75% | = | 100 | × | (324,202) | ÷ | 94,588) |
| Dec 31, 2021 | -264.54% | = | 100 | × | (186,313) | ÷ | 70,428) |
| Dec 31, 2020 | -168.27% | = | 100 | × | (93,943) | ÷ | 55,828) |
| Dec 31, 2019 | -367.97% | = | 100 | × | (98,867) | ÷ | 26,868) |
| Dec 31, 2018 | -282.26% | = | 100 | × | (88,916) | ÷ | 31,501) |
| Dec 31, 2017 | -848.26% | = | 100 | × | (113,396) | ÷ | 13,368) |
| Dec 31, 2016 | 17.56% | = | 100 | × | 18,687) | ÷ | 106,407) |
| Dec 31, 2015 | -130.53% | = | 100 | × | (37,407) | ÷ | 28,658) |
| Dec 31, 2014 | -31.43% | = | 100 | × | (14,754) | ÷ | 46,940) |
| Dec 31, 2013 | -110.59% | = | 100 | × | (33,894) | ÷ | 30,648) |
| Dec 31, 2012 | -535.22% | = | 100 | × | (40,457) | ÷ | 7,559) |
| Dec 31, 2011 | -1,199.10% | = | 100 | × | (47,964) | ÷ | 4,000) |
| Dec 31, 2010 | -1,926.08% | = | 100 | × | (49,635) | ÷ | 2,577) |
| Dec 31, 2009 | 32.00% | = | 100 | × | 26,095) | ÷ | 81,538) |
| Dec 31, 2008 | -475.68% | = | 100 | × | (59,079) | ÷ | 12,420) |
| Dec 31, 2007 | -414.67% | = | 100 | × | (56,487) | ÷ | 13,622) |
| Dec 31, 2006 | -1,961.56% | = | 100 | × | (61,338) | ÷ | 3,127) |
| Dec 31, 2005 | -500.82% | = | 100 | × | (44,633) | ÷ | 8,912) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in thousands
Comparison to Competitors
Cytokinetics Inc., operating profit margin, long-term trends, comparison to competitors
| Cytokinetics Inc. | AbbVie Inc. | Amgen Inc. | Danaher Corp. | Gilead Sciences Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2022 | -342.75% | 31.21% | 38.57% | 27.61% | 27.17% | 38.93% | 18.69% |
| Dec 31, 2021 | -264.54% | 31.89% | 31.44% | 25.35% | 36.72% | 55.67% | 25.57% |
| Dec 31, 2020 | -168.27% | 24.81% | 37.70% | 18.99% | 16.72% | 42.09% | 24.19% |
| Dec 31, 2019 | -367.97% | 39.03% | 43.57% | 18.25% | 19.38% | 28.10% | 17.99% |
| Dec 31, 2018 | -282.26% | 19.49% | 45.55% | 17.11% | 37.83% | 37.77% | 15.53% |
| Dec 31, 2017 | -848.26% | 33.99% | 45.76% | 16.48% | 55.04% | 35.41% | 14.19% |
| Dec 31, 2016 | 17.56% | 36.60% | 44.74% | 16.29% | 58.87% | 27.38% | 13.40% |
| Dec 31, 2015 | -130.53% | 32.97% | 40.44% | 16.87% | 69.03% | 30.51% | 13.77% |
| Dec 31, 2014 | -31.43% | 17.09% | 32.03% | 17.23% | 62.37% | 29.74% | 14.82% |
| Dec 31, 2013 | -110.59% | 30.14% | 32.25% | 17.13% | 41.87% | 36.11% | 12.30% |
| Dec 31, 2012 | -535.22% | 31.65% | 33.52% | 17.33% | 42.67% | 33.20% | 11.85% |
| Dec 31, 2011 | -1,199.10% | — | 28.19% | 16.27% | 46.77% | -46.02% | 10.62% |
| Dec 31, 2010 | -1,926.08% | — | 37.82% | 16.41% | 53.62% | -21.23% | 11.72% |
| Dec 31, 2009 | 32.00% | — | 38.37% | 13.79% | 54.55% | -19.54% | 10.38% |
| Dec 31, 2008 | -475.68% | — | 35.50% | 14.72% | 52.68% | -37.67% | 11.71% |
| Dec 31, 2007 | -414.67% | — | 27.81% | 15.79% | 57.98% | -91.55% | 10.00% |
| Dec 31, 2006 | -1,961.56% | — | 27.71% | 15.82% | -29.32% | -169.68% | 6.38% |
| Dec 31, 2005 | -500.82% | — | 40.33% | 15.84% | 61.41% | -187.97% | 10.01% |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).